{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":655,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":655,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"9648b529e30c","filters":{"venue":"European Journal of Cancer"}},"results":[{"id":"W2019607817","doi":"10.1016/j.ejca.2008.10.026","title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":29472,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Medical Research Council","keywords":"Guideline; Response Evaluation Criteria in Solid Tumors; Medicine; Clinical trial; Clinical endpoint; Pathological; Disease; Target lesion; Progressive disease; Medical physics; Radiology; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07009081787729322,"gpt":0.4234162029133073,"spread":0.3533253850360141,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003338796,0.00008292982,0.0002146615,0.0001531327,0.00004023718,0.000009398826,0.0001304469,0.00001668993,0.001507797],"category_scores_gemma":[0.0009544573,0.0000658615,0.00007599971,0.000204913,0.00004163261,0.00007932893,0.00002472721,0.0002549995,0.00002834322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001688444,"about_ca_system_score_gemma":0.0004988068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002309201,"about_ca_topic_score_gemma":0.000001224738,"domain_scores_codex":[0.9981853,0.0004163523,0.0006670492,0.0001125459,0.0004992149,0.0001195323],"domain_scores_gemma":[0.9987555,0.00004081773,0.0002886184,0.0001896725,0.0005186165,0.000206748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001266459,0.00005243277,0.0008516481,0.000007820003,0.00001155414,0.0003499516,0.0002149329,0.00001846471,0.04834016,0.000002943797,0.891074,0.05780962],"study_design_scores_gemma":[0.004574703,0.0004857828,0.05670002,0.001352956,0.0001374162,0.0006913028,0.00004186806,0.001704857,0.006503518,0.00005528775,0.9276159,0.0001364145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8229696,0.004322436,0.02335219,0.1390579,0.0005033322,0.0006284682,0.000007464202,0.00006684991,0.009091849],"genre_scores_gemma":[0.926128,0.001719917,0.06467466,0.002953544,0.001225706,0.000003650045,0.000007973092,0.00003719671,0.003249377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1361043,"threshold_uncertainty_score":0.999405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2373606074","doi":"10.1016/j.ejca.2016.03.081","title":"RECIST 1.1—Update and clarification: From the RECIST committee","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1894,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; National Cancer Research Institute","keywords":"Response Evaluation Criteria in Solid Tumors; Medicine; Medical physics; Radiology; Disease; Progressive disease; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02242408296974398,"gpt":0.3170312627307039,"spread":0.29460717976096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002968982,0.00006933054,0.0001245368,0.00002138324,0.00008296892,0.00002657281,0.00009291719,0.00001070658,0.0003734255],"category_scores_gemma":[0.0000577356,0.00003043376,0.00004933706,0.00005344315,0.00008391327,0.00007962236,0.00001616593,0.0001087572,0.00003761339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007267913,"about_ca_system_score_gemma":0.00008565142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003778134,"about_ca_topic_score_gemma":0.00002080284,"domain_scores_codex":[0.9993033,0.0001283246,0.0002438411,0.00008520279,0.0001622052,0.00007712717],"domain_scores_gemma":[0.9992548,0.00009361139,0.0002049381,0.0001811945,0.000176863,0.00008861797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002202504,0.00003892681,0.02291673,0.00000366385,0.0003603479,0.0001129253,0.0004494032,7.601432e-7,0.002245894,0.0003192328,0.08184233,0.8914895],"study_design_scores_gemma":[0.001785116,0.000102123,0.249012,0.0002207409,0.0002612474,0.00005147165,0.00006075106,6.067427e-7,0.0002797748,0.0001506128,0.7480345,0.00004103059],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4696411,0.06545828,0.006790713,0.3917363,0.002328979,0.0004842983,0.0002492021,0.00004351158,0.06326764],"genre_scores_gemma":[0.9848295,0.005507943,0.001124479,0.002432642,0.001156635,0.000002280925,0.0000034021,0.00002285207,0.004920198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8914485,"threshold_uncertainty_score":0.4088747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974833358","doi":"10.1016/s0959-8049(00)00186-6","title":"A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients","year":2000,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":805,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Head and neck cancer; Cancer; Head and neck; Reliability (semiconductor); Physical therapy; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02182268262219785,"gpt":0.2851279762464817,"spread":0.2633052936242839,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005078647,0.000197343,0.0005445724,0.00007191984,0.0001641735,0.00002915744,0.0001353658,0.00003020463,0.0002020276],"category_scores_gemma":[0.00004238053,0.0001090955,0.00006230824,0.0001590009,0.0002013957,0.0001159832,0.0000928113,0.0004292076,0.00000170794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007813204,"about_ca_system_score_gemma":0.00007945274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007128309,"about_ca_topic_score_gemma":0.002433315,"domain_scores_codex":[0.9982606,0.0002699949,0.0005613525,0.0002219449,0.000451961,0.0002341624],"domain_scores_gemma":[0.9991508,0.00008864058,0.0002625133,0.000229105,0.0001450847,0.0001239026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004293479,0.0003672761,0.8458492,0.00009482779,0.0001999142,0.000057205,0.01154128,0.00005865547,0.0000853846,0.000004973114,0.01280211,0.1246457],"study_design_scores_gemma":[0.01322601,0.001188189,0.845655,0.001058184,0.00011972,0.00002606392,0.0006124061,0.000017368,0.00004152239,0.000009153669,0.1379309,0.0001154559],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713459,0.01986232,8.67436e-7,0.002248644,0.0003370467,0.0004215549,0.00001564264,0.000004602009,0.005763416],"genre_scores_gemma":[0.9729574,0.02471936,0.00002271991,0.001071422,0.000312894,0.000005353852,5.481307e-7,0.0000254899,0.0008848265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1251288,"threshold_uncertainty_score":0.4448786,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2913276036","doi":"10.1016/j.ejca.2018.11.027","title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort","year":2019,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":726,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Dalhousie University","funders":"National Cancer Institute; Bundesministerium für Bildung und Forschung; Takeda Pharmaceuticals North America; Novartis; Deutsche Krebshilfe; Amgen; Pfizer; Deutsche Forschungsgemeinschaft; European Science Foundation; Eli Lilly and Company; Medical Research Council; AstraZeneca Schweiz; PharmaMar; Bayer","keywords":"Osteosarcoma; Medicine; Cohort; Overall survival; Oncology; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01179583201452263,"gpt":0.2697008094293999,"spread":0.2579049774148773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009822579,0.0002393331,0.0005740442,0.0001860769,0.00003914369,0.00006028607,0.0001676867,0.000009519938,0.00001584974],"category_scores_gemma":[0.00003812825,0.0001278578,0.00006149294,0.0002747104,0.0001285716,0.0001142207,0.00006887096,0.0003158471,0.000006042234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008301143,"about_ca_system_score_gemma":0.00005257656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000387577,"about_ca_topic_score_gemma":0.0005664944,"domain_scores_codex":[0.9975896,0.0008387591,0.000503483,0.0002613167,0.000548212,0.0002585639],"domain_scores_gemma":[0.9990472,0.0001410169,0.00033122,0.0002325118,0.0001172373,0.0001308501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003639379,0.00118993,0.9554219,0.00001531653,0.0001909481,0.001379828,0.002966244,0.000003633412,0.000004997743,0.000002514079,0.00003525029,0.03842552],"study_design_scores_gemma":[0.008282507,0.003240168,0.9833585,0.0002233284,0.0001866162,0.00008176122,0.003827094,0.000002690932,0.000009435026,5.412754e-7,0.0006507562,0.0001365706],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938777,0.001242202,2.467144e-7,0.00172517,0.00008495453,0.0009486384,0.000007277957,0.000006889781,0.002106937],"genre_scores_gemma":[0.9990515,0.0003343819,0.00006572334,0.0003531321,0.00005995833,0.0000125002,0.000002369266,0.00004880749,0.00007166825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03828895,"threshold_uncertainty_score":0.5213891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2917106067","doi":"10.1016/s0959-8049(01)00350-1","title":"Estimates of cancer incidence and mortality in Europe in 1995","year":2002,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":688,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"European Commission","keywords":"Demography; Incidence (geometry); Cancer; Cancer incidence; Population; Mortality rate; Medicine; Quarter (Canadian coin); Cancer registry; Estimation; Geography; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.08907701786376794,"gpt":0.3682597860075627,"spread":0.2791827681437948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007685508,0.0001204031,0.0003881788,0.0001605554,0.00001600002,0.00001288446,0.000140774,0.0000186957,0.0003122424],"category_scores_gemma":[0.0002688497,0.0000979848,0.00004559888,0.0004489638,0.0001032391,0.0001993824,0.00004698031,0.0003170583,0.000003875352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001004994,"about_ca_system_score_gemma":0.00009011204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001113284,"about_ca_topic_score_gemma":0.0008396612,"domain_scores_codex":[0.9985286,0.0001214974,0.0006415432,0.0001416999,0.0003700776,0.000196577],"domain_scores_gemma":[0.9990939,0.00004003647,0.0003467795,0.0001269624,0.0002700981,0.0001221853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001313093,0.00003837949,0.9591687,0.00006364454,0.00003154907,0.001056846,0.0006709742,0.0005700505,0.002374339,0.00001338947,0.0006430333,0.03523784],"study_design_scores_gemma":[0.001310407,0.0002328106,0.9923242,0.001764136,0.00006067341,0.00009455305,0.00009057137,0.0005955981,0.001035513,0.00001955915,0.002378354,0.00009356727],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9619782,0.03279229,0.00002787634,0.0006863676,0.0001378638,0.0000738393,0.000004684742,0.00000426832,0.004294609],"genre_scores_gemma":[0.9913477,0.007491122,0.0004448379,0.0004325488,0.0001610427,0.000001325532,2.149077e-7,0.00001688666,0.0001042735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03514427,"threshold_uncertainty_score":0.3995704,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017845136","doi":"10.1016/j.ejca.2012.08.002","title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials","year":2012,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":589,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Pfizer; Cancer Research UK; Amgen","keywords":"Zoledronic acid; Denosumab; Medicine; Oncology; Internal medicine; Osteoporosis","retraction":null,"screen_n_in":null,"score":{"opus":0.1216288529107031,"gpt":0.4620658469269455,"spread":0.3404369940162424,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004091385,0.0003478859,0.006581069,0.0008785068,0.00003140728,0.000003956283,0.0002031115,0.0001050316,0.0004080329],"category_scores_gemma":[0.0006940911,0.0002387203,0.003507697,0.0008417058,0.00005209118,0.00008813456,0.00003141552,0.0002878996,0.000004423711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002424044,"about_ca_system_score_gemma":0.0008769388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002559386,"about_ca_topic_score_gemma":0.00001574623,"domain_scores_codex":[0.9927498,0.001762679,0.004489717,0.0001985588,0.0005098192,0.0002894936],"domain_scores_gemma":[0.9923673,0.0003127036,0.005879955,0.0003534679,0.0007167489,0.0003698083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01473808,0.001975087,0.000287387,0.01507665,0.02794074,0.0000224355,0.0001919712,0.000006307153,0.0001144954,0.000005862581,0.0001435433,0.9394975],"study_design_scores_gemma":[0.2460473,0.01236174,0.001596872,0.04375776,0.3418548,0.00009345746,0.00004195446,0.0000108632,0.000410246,0.00001340678,0.3533408,0.0004708147],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02164805,0.9744331,0.0003253623,0.00004368152,0.0004589728,0.002663738,0.0003306677,0.000004593647,0.0000918364],"genre_scores_gemma":[0.08105391,0.9178425,0.0003563716,0.00001477793,0.0001392499,0.00004364039,0.0001130658,0.00006929821,0.0003672107],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9390267,"threshold_uncertainty_score":0.9734729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018304470","doi":"10.1016/j.ejca.2012.02.059","title":"Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","year":2012,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":565,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Taiwan University; National Health and Medical Research Council; Queen's University; University of Bristol; Assistance publique-Hôpitaux de Paris; Queen's University Belfast; University of Nottingham; Universidade de São Paulo; University of Leeds; Cancer Research UK","keywords":"Quality of life (healthcare); Sample size determination; Attrition; Sample (material); Medicine; Core (optical fiber); Cancer; Psychology; Meta-analysis; Statistics; Computer science; Pathology; Mathematics; Psychotherapist; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.5597861126265973,"gpt":0.5052095467940746,"spread":0.05457656583252268,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006082021,0.000120264,0.000297145,0.00007227871,0.0001568732,0.00001995082,0.0001625882,0.00001733148,0.00004089414],"category_scores_gemma":[0.002061997,0.00006213985,0.0001729698,0.00009627746,0.0001882514,0.0001124919,0.00002568466,0.00009218154,3.232764e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001542984,"about_ca_system_score_gemma":0.0002805166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009075374,"about_ca_topic_score_gemma":0.001041629,"domain_scores_codex":[0.9982302,0.0004199787,0.0006727571,0.0001168136,0.0003537131,0.0002065251],"domain_scores_gemma":[0.995167,0.001470249,0.0006301379,0.0002051052,0.002420469,0.000107006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006134547,0.0001525392,0.2275078,0.001064769,0.0005006861,0.000001180541,0.01640793,0.00009944345,0.005815199,0.0001719461,0.006625794,0.7355182],"study_design_scores_gemma":[0.009062152,0.00699841,0.8411343,0.01150053,0.001340684,0.00000914914,0.008480393,0.001472444,0.01392813,0.0000776418,0.1056647,0.0003314302],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6353727,0.3098004,0.01542352,0.03456653,0.001820058,0.00270235,0.0002094531,0.00001386711,0.00009114385],"genre_scores_gemma":[0.9888351,0.00650598,0.0002970965,0.000605605,0.003511061,0.0001029732,0.000002337689,0.00004257858,0.00009724937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7351868,"threshold_uncertainty_score":0.253399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033048967","doi":"10.1016/j.ejca.2010.07.028","title":"State of the epidemiological evidence on physical activity and cancer prevention","year":2010,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Physical Activity and Health","field":"Medicine","cited_by":503,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Population; Oncology; Prostate cancer; Prostate; Internal medicine; Cancer; Breast cancer; Vitamin D and neurology; Physiology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.2502526441581736,"gpt":0.4872220340306689,"spread":0.2369693898724954,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001095715,0.0002166084,0.00167749,0.00004815319,0.00005205105,0.000007638644,0.0001978642,0.0000481282,0.0000240497],"category_scores_gemma":[0.0005204043,0.0001022114,0.000592159,0.0001354245,0.0001891346,0.0000993087,0.00007507058,0.001856944,0.000003874216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000115569,"about_ca_system_score_gemma":0.0005947272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001818836,"about_ca_topic_score_gemma":0.000008941914,"domain_scores_codex":[0.9974733,0.001367652,0.0004471649,0.0001883123,0.0003527864,0.0001707743],"domain_scores_gemma":[0.997358,0.00060717,0.001511392,0.0002237615,0.0001358369,0.0001638323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001556196,0.0003040077,0.00003620578,0.003130302,0.0001044529,0.00001311569,0.00004573839,0.000002545155,0.0001470644,0.00001582361,0.0002281941,0.9958169],"study_design_scores_gemma":[0.0004715294,0.001797591,0.02298224,0.08434092,0.00146622,0.00006968265,0.000001498897,0.00001060229,0.0001720738,0.0001598427,0.8883494,0.0001784707],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07717315,0.9206792,0.00002586104,0.001128223,0.0003542317,0.0003401361,0.00002200219,0.000004289477,0.0002729376],"genre_scores_gemma":[0.03806362,0.9603032,0.00002121758,0.0001093866,0.00116894,0.000004896628,2.271324e-7,0.00002398734,0.0003045152],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9956384,"threshold_uncertainty_score":0.80676,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3004209283","doi":"10.1016/j.ejca.2019.11.013","title":"The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients","year":2020,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":478,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University of Toronto","funders":"Janssen Biotech; Springworks Therapeutics; Novartis; PharmaMar; Desmoid Tumor Research Foundation; Bayer; Eli Lilly and Company; Ignyta; AbbVie","keywords":"Guideline; Medicine; Fibromatosis; Sarcoma; Soft tissue sarcoma; Soft tissue; Intensive care medicine; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04859617114621662,"gpt":0.3410442841174882,"spread":0.2924481129712715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008767661,0.0003412619,0.001512438,0.00008198831,0.00008359763,0.00001934353,0.0001947852,0.00002698353,0.000005580685],"category_scores_gemma":[0.0004437287,0.0001978135,0.0005543051,0.0002856407,0.0001551184,0.00001346613,0.0001114655,0.0002706781,0.000002242884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002032515,"about_ca_system_score_gemma":0.0003026407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002255455,"about_ca_topic_score_gemma":6.003784e-7,"domain_scores_codex":[0.9971169,0.0002876331,0.001619123,0.0002366808,0.000506542,0.0002331272],"domain_scores_gemma":[0.9964719,0.0001183067,0.001836029,0.0002132851,0.001175596,0.0001848893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002967492,0.00007747622,0.0001983439,0.01367774,0.00129694,0.0004070589,0.00003150804,0.000005589811,6.321912e-8,0.00001769203,0.03324568,0.9507452],"study_design_scores_gemma":[0.003379533,0.000885174,0.0006592108,0.009010629,0.007108951,0.0001734619,0.0001261712,0.00002397953,7.074217e-7,0.000003225476,0.9784459,0.000183065],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006471991,0.9962577,0.0004270315,0.0006951736,0.0003336379,0.001143879,0.000133638,0.00001081131,0.0009334603],"genre_scores_gemma":[0.0003134264,0.9884735,0.01014509,0.0002732491,0.0006203209,0.00002292734,0.00001772447,0.00006731076,0.00006640771],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9505621,"threshold_uncertainty_score":0.8066598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062393124","doi":"10.1016/j.ejca.2005.08.013","title":"ETS transcription factors and their emerging roles in human cancer","year":2005,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":475,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Transcription factor; Biology; Cell growth; Cancer; Cancer research; Cancer cell; Apoptosis; Programmed cell death; Cell biology; Metastasis; Gene; Immunology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.04574721581244759,"gpt":0.3300207636104653,"spread":0.2842735477980177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004427779,0.000281586,0.0005808733,0.0001250347,0.00004839745,0.00002992752,0.0002193428,0.00008252125,0.00007731252],"category_scores_gemma":[0.00001169599,0.0001913048,0.0002694508,0.00006694947,0.00004078785,0.000006984376,0.00003744922,0.0003505608,8.400529e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004257957,"about_ca_system_score_gemma":0.0001237624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001212467,"about_ca_topic_score_gemma":0.0001231164,"domain_scores_codex":[0.9985924,0.0003808776,0.0005416721,0.0001996854,0.0001010637,0.0001842999],"domain_scores_gemma":[0.9992632,0.000006736915,0.0004680394,0.0001197412,0.00005355621,0.00008867828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009791818,0.00001419039,0.0001003423,0.000504142,0.0001090764,0.00001099396,0.0002736149,0.000009013878,0.005642344,0.00000236733,0.0002090786,0.9931151],"study_design_scores_gemma":[0.0002792915,0.0001048007,0.0001553568,0.003908926,0.0000973851,0.00002433061,0.00004293072,3.660865e-7,0.002005391,0.000001850218,0.9931695,0.0002098104],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01853924,0.9803503,0.00002520465,0.00003493067,0.0002071795,0.0001270321,0.00005044565,0.000002823251,0.0006628845],"genre_scores_gemma":[0.02358023,0.9749009,0.00001940927,0.00004608818,0.001163186,0.000005813959,0.00001687647,0.00005897813,0.0002085235],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9929605,"threshold_uncertainty_score":0.7801185,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906639914","doi":"10.1016/j.ejca.2018.11.024","title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":468,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"European Organisation for Research and Treatment of Cancer; Austrian Science Fund","keywords":"Normative; Quality of life (healthcare); Gerontology; Population; Psychology; Environmental health; Medicine; Demography; Political science; Sociology; Psychotherapist; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.04260858412250067,"gpt":0.3377271839897089,"spread":0.2951185998672082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004265709,0.0001420639,0.0003473293,0.00003505339,0.0003455813,0.00004382956,0.0002857812,0.00001353415,0.00004666001],"category_scores_gemma":[0.0005294087,0.00007831564,0.00006412202,0.0001516057,0.0003257981,0.0001120734,0.00005509823,0.0002558017,7.232377e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001682976,"about_ca_system_score_gemma":0.0008422595,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3665684,"about_ca_topic_score_gemma":0.6654865,"domain_scores_codex":[0.9971368,0.001316895,0.0007406118,0.0001486769,0.0004568712,0.0002001469],"domain_scores_gemma":[0.9975138,0.0003594315,0.0009275363,0.0004018641,0.000643291,0.0001540475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0348314,0.0002493221,0.4358216,0.001653049,0.002472905,0.00009257776,0.09319579,0.007881165,0.00008574785,0.001255062,0.3015389,0.1209225],"study_design_scores_gemma":[0.007048852,0.0007686153,0.8875332,0.0008671663,0.0001946772,0.00002032839,0.004358866,0.006674201,0.00003150398,0.00001924831,0.0922882,0.0001950786],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9570427,0.009918183,0.001182119,0.02835271,0.0009925812,0.0004703491,0.001570226,0.00001414561,0.0004569832],"genre_scores_gemma":[0.9927931,0.000412404,0.00003644407,0.005714188,0.0006784702,0.000001849975,0.00009264123,0.00003076197,0.0002401796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4517117,"threshold_uncertainty_score":0.6376497,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2601178524","doi":"10.1016/j.ejca.2017.02.027","title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017","year":2017,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":449,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Takeda Oncology; Galderma; Eisai; Therakos; Teva Pharmaceutical Industries","keywords":"Mycosis fungoides; Dermatology; Medicine; Cancer; Oncology; Internal medicine; Lymphoma","retraction":null,"screen_n_in":null,"score":{"opus":0.4181450144113252,"gpt":0.5248697132950937,"spread":0.1067246988837685,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001799526,0.0003767674,0.001716655,0.0004291041,0.0004111032,0.00006887877,0.0003528604,0.00005793901,0.0001964167],"category_scores_gemma":[0.0002778761,0.0002194537,0.0006115354,0.0001392948,0.0004381528,0.00004887602,0.00005006223,0.0001938896,0.00000806889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009403599,"about_ca_system_score_gemma":0.001599029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001578708,"about_ca_topic_score_gemma":0.0001465966,"domain_scores_codex":[0.9965296,0.001006923,0.001241617,0.0003446441,0.0004958434,0.0003814169],"domain_scores_gemma":[0.9946649,0.001277875,0.001694406,0.0006361901,0.001524933,0.0002016758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000750455,0.0005106779,0.0001798396,0.002324125,0.00302913,0.0001612188,0.0008281734,0.000003081384,0.00004299217,0.00001423018,0.007046104,0.98511],"study_design_scores_gemma":[0.00361826,0.00741847,0.0003681168,0.005039681,0.002597417,0.0008152943,0.0002043625,0.00001302708,0.00008165433,0.0000115503,0.9796737,0.0001584396],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001572728,0.9898324,0.00003872133,0.003082653,0.0003128013,0.003364474,0.001298468,0.000005465395,0.0004922992],"genre_scores_gemma":[0.001890534,0.9930707,0.0003751007,0.00001920772,0.0005283282,0.0001818834,0.00008314966,0.0001459429,0.003705102],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849516,"threshold_uncertainty_score":0.894906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076679216","doi":"10.1016/j.ejca.2010.02.027","title":"Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth","year":2010,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":382,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Dormancy; Extracellular matrix; Fibronectin; Stromal cell; Crosstalk; Integrin; Cell biology; Biology; Cancer research; Cell; Botany; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02453810952803146,"gpt":0.3227761259830812,"spread":0.2982380164550497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007495654,0.000214706,0.0004442651,0.0001293771,0.00003756425,0.00005681718,0.0004494935,0.00005826513,0.0001554396],"category_scores_gemma":[0.00004309774,0.000139205,0.0004270881,0.0001396922,0.00001382006,0.000007110268,0.00003255474,0.0005867133,0.00003967455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002211918,"about_ca_system_score_gemma":0.000126128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001817786,"about_ca_topic_score_gemma":0.00003962058,"domain_scores_codex":[0.998302,0.0005298284,0.0006320617,0.0001881494,0.0001938072,0.0001541402],"domain_scores_gemma":[0.9991291,0.00002119409,0.0003976151,0.0002521772,0.0001218695,0.00007809071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000583827,0.0001361625,6.013956e-7,0.0005186307,0.0003392085,0.0003998381,0.0004952251,0.00002116411,0.02581664,0.0001032383,0.004196021,0.9679149],"study_design_scores_gemma":[0.0002085416,0.0001620518,0.0000028254,0.001313775,0.0003875739,0.0001354264,0.00004009102,0.000002714032,0.0003134037,0.00001632384,0.9972574,0.0001598959],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000937036,0.9947162,0.002961435,0.0002089356,0.0006722413,0.0002136651,0.00006758693,0.000001486622,0.0002213746],"genre_scores_gemma":[0.001527335,0.9963006,0.000487128,0.0001404421,0.001052661,0.00001096688,0.00006665699,0.00005520737,0.0003589703],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9930614,"threshold_uncertainty_score":0.5676617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2397768676","doi":"10.1016/j.ejca.2016.03.082","title":"RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group","year":2016,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Response Evaluation Criteria in Solid Tumors; Medicine; Clinical trial; Medical physics; Clinical endpoint; Biomarker; Imaging biomarker; Radiology; Phases of clinical research; Internal medicine; Magnetic resonance imaging","retraction":null,"screen_n_in":null,"score":{"opus":0.05869387304731272,"gpt":0.3462172372383782,"spread":0.2875233641910655,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001420628,0.0002292712,0.0007565885,0.0001060552,0.0001643066,0.0001162303,0.00021529,0.00002865951,0.0002050424],"category_scores_gemma":[0.0009367942,0.0001161779,0.0003312728,0.0001323688,0.0002701978,0.00007848246,0.00004721131,0.000811192,0.00001037496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002700333,"about_ca_system_score_gemma":0.0002972714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007465061,"about_ca_topic_score_gemma":0.000001709701,"domain_scores_codex":[0.9977061,0.000727528,0.0006782851,0.0002458243,0.0004894435,0.0001528086],"domain_scores_gemma":[0.9978621,0.0005512132,0.0008705794,0.0002462193,0.000178735,0.0002911403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008264116,0.00001369294,0.00005741397,0.0001691543,0.0002473563,0.0001867851,0.0006172766,9.687158e-7,0.000001440553,0.0001504748,0.009310725,0.9891621],"study_design_scores_gemma":[0.0005949429,0.00005123229,0.00110415,0.0387699,0.0007598386,0.00007710238,0.0002681348,0.000005460375,1.984049e-8,0.00007756668,0.9581641,0.000127531],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000024684,0.9887686,0.00406142,0.003787645,0.0007828773,0.0002087302,0.0000430011,0.0000120083,0.002311069],"genre_scores_gemma":[0.0003955052,0.9929895,0.0009496615,0.0001807033,0.004794102,0.000004150248,0.00001260764,0.00007824313,0.0005955435],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9890345,"threshold_uncertainty_score":0.4737596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059931397","doi":"10.1016/s0959-8049(01)00083-1","title":"A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma","year":2001,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":378,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Ifosfamide; Surgery; Chemotherapy; Amputation; Radiation therapy; Soft tissue; Nausea; Soft tissue sarcoma; Sarcoma; Doxorubicin; Cisplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.02286897510768976,"gpt":0.3322139599562557,"spread":0.3093449848485659,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006407427,0.0002400708,0.00062507,0.0001366486,0.0001535294,0.00002801494,0.0001462971,0.00001982563,0.0003268134],"category_scores_gemma":[0.0001582614,0.0001588536,0.0002503071,0.0001272544,0.00003231607,0.00006029122,0.00001658342,0.0002195553,0.00002009312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001201804,"about_ca_system_score_gemma":0.00008005277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003812718,"about_ca_topic_score_gemma":0.00001522839,"domain_scores_codex":[0.9982464,0.0002363705,0.0006297888,0.0002172271,0.000407793,0.0002624567],"domain_scores_gemma":[0.9984491,0.0001567567,0.0005206491,0.0002613735,0.0003747496,0.0002373702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04166716,0.008383639,0.02235568,0.00001319729,0.001056097,0.002415064,0.001918452,0.00002959972,0.001193343,0.00001052348,0.01011274,0.9108445],"study_design_scores_gemma":[0.6243932,0.05305194,0.1583169,0.0005873698,0.001653245,0.0003041005,0.0007312663,0.00005087861,0.009916221,0.00004515188,0.150585,0.0003647982],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890306,0.003969865,0.0005698941,0.004135329,0.000405051,0.00120661,0.00001968325,0.000020773,0.0006421673],"genre_scores_gemma":[0.9939616,0.001789472,0.0004770451,0.001688782,0.001250196,0.00004432891,0.000003052261,0.00007741291,0.0007080522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9104797,"threshold_uncertainty_score":0.6477863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2119349383","doi":"10.1016/j.ejca.2015.07.017","title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.306547317567451,"gpt":0.4112477314974096,"spread":0.1047004139299585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001087484,0.0001037287,0.0002808648,0.00006535737,0.00004132515,0.00002136616,0.0001746596,0.00001713586,0.0001068352],"category_scores_gemma":[0.0002955379,0.00005854783,0.0001563232,0.0001774366,0.00007343553,0.0001069357,0.00003691865,0.0002222103,0.000008145033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001538072,"about_ca_system_score_gemma":0.0003646255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001280579,"about_ca_topic_score_gemma":0.0000192012,"domain_scores_codex":[0.9983853,0.0002289831,0.0004844955,0.0000851773,0.0006617312,0.0001543415],"domain_scores_gemma":[0.9985192,0.00004247766,0.0005009173,0.0001802229,0.0005681881,0.0001889755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.167362,0.0003204213,0.03056221,0.00005922886,0.001458088,0.00234297,0.004829105,0.001245095,0.007216297,0.00005734049,0.1087346,0.6758126],"study_design_scores_gemma":[0.284961,0.02635628,0.2614028,0.005868429,0.003290639,0.001631552,0.005110176,0.0003387995,0.03687188,0.0001748157,0.373252,0.0007415668],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645584,0.01518097,0.000555902,0.001838043,0.0008030956,0.0002335954,0.000008422896,0.00001135984,0.0168102],"genre_scores_gemma":[0.9969782,0.0002050364,0.000643419,0.0003759947,0.001450439,0.00000105503,6.786198e-7,0.00001839415,0.0003267849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.675071,"threshold_uncertainty_score":0.2387511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1799482054","doi":"10.1016/j.ejca.2015.03.015","title":"Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":337,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University Health Network; University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Cetuximab; Medicine; KRAS; Internal medicine; Colorectal cancer; Oncology; Hazard ratio; Proportional hazards model; Epidermal growth factor receptor; Refractory (planetary science); Splenic flexure; Cancer; Gastroenterology; Confidence interval; Colonoscopy; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04018596104969974,"gpt":0.3208746865091295,"spread":0.2806887254594298,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002025648,0.000159876,0.0005381946,0.0001347158,0.00002320318,0.000009475396,0.00008585541,0.00002868848,0.0001601117],"category_scores_gemma":[0.0003495577,0.0001168943,0.00006299964,0.0001672714,0.0001086726,0.0001016292,0.00003482719,0.000161292,0.000001917378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003295217,"about_ca_system_score_gemma":0.0005571092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009381041,"about_ca_topic_score_gemma":0.001538511,"domain_scores_codex":[0.9986045,0.00008731088,0.0005655431,0.0001596249,0.0004252171,0.0001577606],"domain_scores_gemma":[0.9982871,0.0001421082,0.0005404392,0.0001173752,0.000751297,0.0001616779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02975624,0.0008111629,0.8912815,0.0003844606,0.002120956,0.0006064733,0.01837196,0.0003545055,0.006963641,0.00002678665,0.004589533,0.0447328],"study_design_scores_gemma":[0.01772936,0.004977703,0.9645892,0.002569127,0.0005740181,0.00002395908,0.0007037734,0.00006579794,0.005689068,0.00004919089,0.00287898,0.0001498452],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675257,0.02953825,0.000008683612,0.0004418391,0.0003992159,0.0002748029,0.00007278815,0.000006205964,0.001732562],"genre_scores_gemma":[0.997896,0.001401184,0.0001125968,0.00005633356,0.0002452899,0.000007577117,0.000004390321,0.0000236839,0.0002529507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07330769,"threshold_uncertainty_score":0.4766811,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008798432","doi":"10.1016/j.ejca.2020.01.008","title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Canada; Janssen Pharmaceuticals; Merck Sharp and Dohme; NeraCare; Sun Pharma; Universidad de Cantabria; ZonMw; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Vertex Pharmaceuticals; Mylan; Regeneron Pharmaceuticals; Eisai Korea; Agence Nationale de la Recherche; F. Hoffmann-La Roche; Millennium Challenge Corporation; Università Degli Studi di Modena e Reggio Emila; Immunocore; Novartis Pharma; AbbVie; Novartis; Celgene; Pfizer; Biogen; Arthrex GmbH; LEO Pharma; LEO Pharma Research Foundation; Wyeth; Janssen Biotech; Les Laboratories Pierre Fabre; Meso Scale Diagnostics; Sanofi; Roche; Merck; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Leo Baeck Institute; Bristol-Myers Squibb; Amgen; Meadows Foundation; EMD Serono; Almirall; Galderma; BioNTech","keywords":"Medicine; Cetuximab; Systemic therapy; Radiation therapy; Guideline; Oncology; Lymph node; Internal medicine; Cancer; Dissection (medical); Surgery; Pathology; Colorectal cancer; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03598642157108808,"gpt":0.2937085446046721,"spread":0.257722123033584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003512881,0.0002308159,0.0004551319,0.00005941627,0.00008422104,0.00001092751,0.000320267,0.00001292013,0.000183184],"category_scores_gemma":[0.0001008694,0.0001332387,0.0003573622,0.0001716808,0.0001253946,0.00004528707,0.0002879145,0.0002752641,0.00004451131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002143526,"about_ca_system_score_gemma":0.0002152213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007311326,"about_ca_topic_score_gemma":0.00001115193,"domain_scores_codex":[0.9978811,0.0004376328,0.0008593399,0.0002100057,0.0004152512,0.0001966606],"domain_scores_gemma":[0.9983578,0.00007569108,0.0007548381,0.0003176259,0.0002958809,0.0001981148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.006065994,0.00119439,0.1623578,0.0005377994,0.001015845,0.008326916,0.03795807,0.001897956,0.01218768,0.00002371214,0.6836668,0.08476707],"study_design_scores_gemma":[0.01091052,0.01397888,0.5384039,0.0009024143,0.0008845864,0.0002849489,0.002241658,0.00002508109,0.0873372,0.000008812999,0.3446452,0.0003767991],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.862914,0.007859004,0.00004260435,0.02372936,0.001024104,0.0003008053,0.00004010168,0.00001143912,0.1040786],"genre_scores_gemma":[0.9935687,0.0003112041,0.0001706699,0.002504922,0.002454275,0.000001628891,0.000001526337,0.00006798292,0.0009190491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3760461,"threshold_uncertainty_score":0.5433316,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069655417","doi":"10.1016/j.ejca.2007.01.025","title":"Multidisciplinary cancer conferences: A systematic review and development of practice standards","year":2007,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Multidisciplinary approach; Medicine; Systematic review; Health care; Medical education; Best practice; MEDLINE; Family medicine; Nursing; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.2113469562614895,"gpt":0.4910460176024804,"spread":0.2796990613409909,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004770611,0.0003352972,0.003226042,0.0002030711,0.00004997929,0.00001973657,0.0002491136,0.00005606002,0.0003235031],"category_scores_gemma":[0.0007738536,0.0002092273,0.0002750691,0.0002591477,0.00008961206,0.0001209194,0.00009394867,0.000505284,0.000007951234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004333426,"about_ca_system_score_gemma":0.004283485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001622402,"about_ca_topic_score_gemma":0.00001942841,"domain_scores_codex":[0.9958284,0.0005252313,0.002187714,0.0002087622,0.001029129,0.0002207655],"domain_scores_gemma":[0.9944094,0.0001624191,0.003535128,0.0002284959,0.001417278,0.0002472678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004218717,0.00002082733,0.000009270982,0.6067111,0.0008781839,0.0003551223,0.0002904566,2.257813e-7,2.647905e-7,0.00000611989,0.001071838,0.3906144],"study_design_scores_gemma":[0.0002255293,0.0001110499,0.0000130692,0.4904003,0.006250411,0.0005287256,0.0001214148,9.32287e-8,8.558844e-7,1.415738e-7,0.5022418,0.0001066623],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002058678,0.9889724,0.000368016,0.0001111555,0.0001690592,0.0008889549,0.00003481111,0.000007484376,0.009446073],"genre_scores_gemma":[0.00002066679,0.9952597,0.003476523,0.0002722587,0.0001943325,0.00001691764,0.00000223524,0.00006838325,0.0006889855],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5011699,"threshold_uncertainty_score":0.8532044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156982018","doi":"10.1016/s0959-8049(00)00102-7","title":"Insulin-like growth factor physiology and cancer risk","year":2000,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Population; Physiology; Risk factor; Cancer; Prostate cancer; Circumstantial evidence; Medicine; Biology; Bioinformatics; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.03579919376791735,"gpt":0.3143583510342707,"spread":0.2785591572663534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004899976,0.0007323677,0.00290515,0.0005041305,0.0001188699,0.00004496994,0.0003982987,0.0002094655,0.001139123],"category_scores_gemma":[0.0001311736,0.0004918677,0.0008819018,0.0004032933,0.0002094763,0.0001837063,0.0000969114,0.001964666,0.00009988779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002376256,"about_ca_system_score_gemma":0.0008374191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000683101,"about_ca_topic_score_gemma":0.000003446331,"domain_scores_codex":[0.9959579,0.0008929701,0.001648563,0.0004850233,0.0005045736,0.0005109879],"domain_scores_gemma":[0.9966045,0.0001498116,0.001909582,0.0003663551,0.000402058,0.0005676909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001937597,0.00007199882,0.0003981184,0.00357756,0.001107598,0.0003647013,0.0002239985,6.068186e-7,0.00001474669,0.000002801909,0.006771,0.9872731],"study_design_scores_gemma":[0.00148769,0.0006205211,0.007340635,0.008384239,0.003117542,0.0004174336,0.00001006988,8.438809e-7,0.0000104069,0.000009242511,0.9781556,0.0004458212],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00520448,0.9906411,0.000006003091,0.0001058063,0.001414909,0.0003808009,0.000244248,0.00003029491,0.001972406],"genre_scores_gemma":[0.001819859,0.99353,0.00009555752,0.0004629424,0.002934531,0.000008756102,0.00001644255,0.0002079532,0.0009239945],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9868273,"threshold_uncertainty_score":0.999774,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164547129","doi":"10.1016/j.ejca.2008.10.028","title":"Evaluation of lymph nodes with RECIST 1.1","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Lymph; Medicine; Lymph node; Malignancy; Radiology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0825629448717539,"gpt":0.3670388252229543,"spread":0.2844758803512004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222149,0.00004405033,0.0001324119,0.0000468099,0.00002473288,0.000002190681,0.00006869961,0.000006427519,0.000229011],"category_scores_gemma":[0.0001197891,0.00002797552,0.0000399262,0.00009651606,0.00009785857,0.00003282928,0.000007803515,0.00008975679,0.000003649172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000502613,"about_ca_system_score_gemma":0.0002684401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008280985,"about_ca_topic_score_gemma":3.68074e-7,"domain_scores_codex":[0.9988956,0.0001030292,0.0002459032,0.00005015387,0.0006501686,0.00005514901],"domain_scores_gemma":[0.9986244,0.00001415737,0.0002384585,0.0001147645,0.0009298291,0.00007838439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0004650317,0.0004431392,0.04819816,0.00007905223,0.0003626626,0.0003445301,0.000892386,0.0002536213,0.04712478,0.0001817108,0.08133242,0.8203225],"study_design_scores_gemma":[0.01060754,0.001056077,0.7065259,0.002727385,0.002039126,0.003616113,0.000146183,0.002912845,0.0468651,0.0002199748,0.2229934,0.0002903068],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9425802,0.001887556,0.009116873,0.00555665,0.00006721742,0.0001347679,0.000002814458,0.0000175625,0.04063638],"genre_scores_gemma":[0.9865546,0.0005188198,0.01202341,0.00024246,0.0002227848,0.000001967247,6.070122e-7,0.0000124795,0.0004228485],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8200322,"threshold_uncertainty_score":0.250751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041130945","doi":"10.1016/j.ejca.2004.10.017","title":"Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group","year":2004,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":293,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University; Telus (Canada)","funders":"","keywords":"Interpretation (philosophy); Clinical trial; Quality of life (healthcare); Baseline (sea); Meaning (existential); Medicine; Medical physics; Psychology; Computer science; Psychotherapist; Pathology; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.8171980228626496,"gpt":0.5882876650280776,"spread":0.228910357834572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2777488,0.0001536854,0.004265682,0.0003009379,0.00006403114,0.00001532626,0.0007295097,0.00008294026,0.0001604595],"category_scores_gemma":[0.07226151,0.0001307148,0.000604883,0.0004513804,0.00028929,0.0003584302,0.0001176655,0.0003734739,0.000001351534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003524788,"about_ca_system_score_gemma":0.004013266,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1361359,"about_ca_topic_score_gemma":0.06121539,"domain_scores_codex":[0.9441301,0.0189833,0.03567007,0.0004872086,0.0005190229,0.00021029],"domain_scores_gemma":[0.9528205,0.006022035,0.03999859,0.0004962216,0.0004698267,0.0001927576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001852346,0.0008840421,0.8772725,0.001168886,0.01505245,0.000001032853,0.003678626,0.04928257,0.00002590961,0.0102714,0.01671296,0.02379728],"study_design_scores_gemma":[0.007315487,0.0001937739,0.9757355,0.0006478966,0.0004811592,0.000001024356,0.0005740004,0.008279354,0.000007911705,0.001379502,0.005167327,0.0002170935],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.938427,0.02024405,0.01876134,0.01389317,0.002967002,0.0005868111,0.004600202,0.000003305519,0.0005171613],"genre_scores_gemma":[0.9940955,0.00185391,0.001799395,0.001643257,0.0005136277,0.000003389899,0.00004862575,0.00001778294,0.00002449588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2054873,"threshold_uncertainty_score":0.955915,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2774227900","doi":"10.1016/j.ejca.2017.10.021","title":"Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"F. Hoffmann-La Roche; Roche","keywords":"Pertuzumab; Anthracycline; Trastuzumab; Medicine; Oncology; Internal medicine; Chemotherapy; Cancer; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02363119783183756,"gpt":0.3797801121478566,"spread":0.356148914316019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002932904,0.0003779013,0.001651593,0.0003422575,0.0005803299,0.0001261701,0.0005458033,0.00004772126,0.0001085092],"category_scores_gemma":[0.0004384793,0.0002377097,0.0002901438,0.0003942178,0.0006151546,0.0003065167,0.0002615075,0.0007698683,1.628172e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006893111,"about_ca_system_score_gemma":0.0008224472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006312401,"about_ca_topic_score_gemma":0.0004534345,"domain_scores_codex":[0.9954165,0.0009722508,0.001164802,0.0004866115,0.001504737,0.0004551047],"domain_scores_gemma":[0.9959635,0.0002571979,0.001538716,0.0008692293,0.001065003,0.0003063448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0806468,0.0006203529,0.6994997,0.00004876893,0.003111351,0.0001579506,0.008824017,0.0002534033,0.0004017852,2.874376e-7,0.00003087272,0.2064047],"study_design_scores_gemma":[0.1508611,0.00690232,0.8369601,0.001724548,0.002326074,0.00001853522,0.0004957706,0.0002483084,0.0002265923,4.888959e-7,0.00002513422,0.0002110326],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930708,0.002802335,0.00005407252,0.001784752,0.0002028187,0.001577295,0.0003471153,0.000007642526,0.00015312],"genre_scores_gemma":[0.9975265,0.001786866,0.0001041864,0.00009144741,0.0003052286,0.00001489056,0.000004198244,0.00008525248,0.00008139956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2061937,"threshold_uncertainty_score":0.969352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161243824","doi":"10.1016/j.ejca.2015.07.006","title":"Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials","year":2015,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Systematic sampling; Confidence interval; Sampling (signal processing); Meta-analysis; Cervical cancer; Population; Sample size determination; Randomized controlled trial; Physical therapy; Demography; Cancer; Surgery; Internal medicine; Environmental health; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.4234908454320741,"gpt":0.4853201520069705,"spread":0.06182930657489644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.05210375,0.0005412836,0.01682003,0.0005710148,0.00006947924,0.0001452491,0.0005674366,0.00009024297,0.0006904041],"category_scores_gemma":[0.002703153,0.0002621302,0.002968285,0.00152358,0.0000847716,0.0001154511,0.000140285,0.001291119,0.000001245656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000472747,"about_ca_system_score_gemma":0.0005407339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008722796,"about_ca_topic_score_gemma":0.00002092583,"domain_scores_codex":[0.9822513,0.01022953,0.004816463,0.0004262502,0.001661437,0.0006149651],"domain_scores_gemma":[0.9929511,0.001555744,0.003581438,0.0006233047,0.0007993447,0.0004890987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0009155044,0.0001035813,0.000005294416,0.6542888,0.182015,0.0002067572,0.002156569,0.00003543559,9.617635e-7,0.000005440021,0.0002619701,0.1600046],"study_design_scores_gemma":[0.005056472,0.0002303606,0.0000183261,0.06836405,0.8160116,0.00008849779,0.0001778626,0.0000379263,5.655593e-7,0.000002512274,0.1097379,0.000273908],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004311665,0.9952128,0.0001196263,0.0007300909,0.00003813787,0.003517656,0.00009573413,0.000010447,0.0002323711],"genre_scores_gemma":[0.0006512094,0.9975441,0.0001586877,0.0005663214,0.0002392015,0.0006409773,0.00001036084,0.00008842019,0.0001007112],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6339966,"threshold_uncertainty_score":0.9999831,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990256102","doi":"10.1016/j.ejca.2008.02.030","title":"Predicting survival in patients with advanced disease","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Medicine; Disease; Cancer; Intensive care medicine; Malignancy; Palliative care; Anorexia; Performance status; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0595708918678473,"gpt":0.3516866171460519,"spread":0.2921157252782046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001540455,0.00007318427,0.0002107463,0.00007375361,0.00001768984,0.000001815491,0.00006035197,0.000005610071,0.00003732596],"category_scores_gemma":[0.0001635194,0.00005032413,0.00004828709,0.0001100907,0.00004781464,0.00009172328,0.00001185335,0.0001432933,0.000001982648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000047024,"about_ca_system_score_gemma":0.0001107796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006896101,"about_ca_topic_score_gemma":0.000005213471,"domain_scores_codex":[0.999134,0.00008506897,0.0002818974,0.00006841228,0.0003254966,0.0001051395],"domain_scores_gemma":[0.999227,0.00002940614,0.0002333053,0.0000781308,0.0002938276,0.0001383358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001565387,0.00007877288,0.9896914,0.00002613156,0.00004261547,0.0004127744,0.0009465399,0.0002275634,0.00003421858,0.000001113259,0.0001504314,0.006823099],"study_design_scores_gemma":[0.004125445,0.0004921409,0.9859242,0.001415437,0.00004059995,0.000002877153,0.00009025347,0.000007059308,0.0001262507,8.751455e-7,0.007722866,0.00005199646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936139,0.003117619,0.00005254985,0.0001415949,0.0001785228,0.00005803213,0.000006873173,0.000004527771,0.002826395],"genre_scores_gemma":[0.998074,0.0009431026,0.0005162434,0.0000938805,0.0002084037,3.873718e-7,0.000001704717,0.00001786138,0.0001444348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007572435,"threshold_uncertainty_score":0.2052158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1702502468","doi":"10.1016/j.ejca.2015.07.035","title":"A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":272,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"National Cancer Institute; Small Business Innovation Research","keywords":"Medicine; Vaccine therapy; Lung cancer; Maintenance therapy; Cell; Cancer; Cell therapy; Cancer research; Oncology; Immunology; Immunotherapy; Internal medicine; Biology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02318868574445882,"gpt":0.3017719594808618,"spread":0.278583273736403,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001492289,0.0003228149,0.0006601653,0.0002025835,0.0001504437,0.0000267649,0.0007295221,0.00007385589,0.0003401404],"category_scores_gemma":[0.00003242205,0.000244918,0.0002306997,0.0001644255,0.00006426767,0.000193886,0.00005429811,0.0003900249,0.00001549069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009049485,"about_ca_system_score_gemma":0.0005488262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002403679,"about_ca_topic_score_gemma":0.00004854365,"domain_scores_codex":[0.9972453,0.0009716963,0.0009602821,0.000270387,0.0001035978,0.0004487141],"domain_scores_gemma":[0.99765,0.00009167907,0.001142107,0.0003562013,0.0006783466,0.00008167312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0256433,0.00334004,0.001158071,0.00003501623,0.0006827232,0.00006715755,0.01134675,0.0002456353,0.9279138,0.000002445219,0.01100715,0.01855785],"study_design_scores_gemma":[0.1159693,0.02402643,0.005350961,0.000236788,0.0003581403,0.0001207755,0.006282587,0.00002078072,0.7357297,0.000008122938,0.1113355,0.0005608803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9177476,0.07903288,0.0004027734,0.0001118716,0.001397658,0.0007065296,0.00003427822,0.00001470878,0.0005516529],"genre_scores_gemma":[0.9892273,0.004552588,0.0001085242,0.0003403015,0.000198509,0.00003301628,0.000006188119,0.00008802518,0.005445571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1921841,"threshold_uncertainty_score":0.9987466,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054521520","doi":"10.1016/j.ejca.2008.02.028","title":"Management of malignant bowel obstruction","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Bowel obstruction; Vomiting; Octreotide; Gastric outlet obstruction; Abdominal pain; Palliative care; Radiological weapon; Ascites; Surgery; General surgery; Intensive care medicine; Somatostatin; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03170376239179645,"gpt":0.2819649146939523,"spread":0.2502611523021558,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000151879,0.00005574924,0.0001324921,0.00005310559,0.0000356726,0.000001715576,0.00005862897,0.00000625611,0.0002794296],"category_scores_gemma":[0.00000944314,0.00003835168,0.00009037042,0.00007248358,0.00004896973,0.00003583518,0.00001563142,0.0001095995,0.00001784979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002665681,"about_ca_system_score_gemma":0.0000319402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000774902,"about_ca_topic_score_gemma":2.994795e-7,"domain_scores_codex":[0.9993127,0.00003998518,0.0002999039,0.00004975811,0.0002186957,0.00007897706],"domain_scores_gemma":[0.9994441,0.000006498955,0.0001982922,0.00007119637,0.0002048373,0.00007502384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004774711,0.0009717813,0.1420648,0.00136549,0.001598915,0.05655604,0.004469255,0.0007274274,0.1757507,0.001669588,0.06848069,0.5415707],"study_design_scores_gemma":[0.001229707,0.0008213827,0.8874026,0.001216961,0.0001715769,0.004174178,0.0001996867,0.00001387437,0.01290418,0.00002543497,0.09175876,0.00008165722],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683148,0.001407487,0.0001571158,0.0008478963,0.0004243062,0.00004506913,0.000002321336,0.000005375376,0.0287956],"genre_scores_gemma":[0.9895555,0.001562224,0.002992031,0.0001159243,0.00038427,3.269868e-7,3.81367e-7,0.00001183225,0.005377478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7453378,"threshold_uncertainty_score":0.3059559,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905201605","doi":"10.1016/j.ejca.2018.11.015","title":"Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University Health Centre","funders":"AstraZeneca; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Head and neck; Basal cell; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Head and neck cancer; Surgery; Cancer; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.0346955478729249,"gpt":0.3084686780840385,"spread":0.2737731302111136,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006078098,0.0003120438,0.0005459217,0.0001957679,0.0001317497,0.00004665508,0.000151107,0.00002581694,0.00009174229],"category_scores_gemma":[0.00006169832,0.0001954284,0.000100014,0.0001700813,0.0001022502,0.0001038122,0.00002155495,0.0002573861,8.612971e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002127247,"about_ca_system_score_gemma":0.0002492484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005287823,"about_ca_topic_score_gemma":0.0001387528,"domain_scores_codex":[0.9976248,0.0003181252,0.0008337063,0.0003803569,0.0005442464,0.0002987421],"domain_scores_gemma":[0.998182,0.0001338963,0.0008713726,0.0002623287,0.0003759645,0.0001744335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8156959,0.02382539,0.03045259,0.000185379,0.0001613498,0.0003711314,0.01233455,0.00002611776,0.01744929,3.641933e-8,0.005153936,0.09434427],"study_design_scores_gemma":[0.3934141,0.278205,0.2388998,0.002215467,0.0003281097,0.000006551958,0.0009185763,0.0003541874,0.07941999,0.000001254399,0.00579448,0.0004424875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965283,0.0009571575,0.00005938823,0.0002602364,0.0002235272,0.001525544,0.0001798135,0.00001129526,0.0002547376],"genre_scores_gemma":[0.9975991,0.00001714996,0.001354494,0.0003761571,0.000318567,0.00001819283,0.00002287446,0.00008171709,0.0002117986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4222819,"threshold_uncertainty_score":0.7969338,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018626410","doi":"10.1016/s0959-8049(02)80597-4","title":"Regulation and targets of receptor tyrosine kinases","year":2002,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":262,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Autophosphorylation; Cell biology; Receptor tyrosine kinase; Signal transduction; Phosphorylation; SH2 domain; Phosphotyrosine-binding domain; Receptor Protein-Tyrosine Kinases; Biology; Signal transducing adaptor protein; PDZ domain; Tyrosine phosphorylation; Chemistry; Protein kinase A","retraction":null,"screen_n_in":null,"score":{"opus":0.1000962564019976,"gpt":0.3337335402007452,"spread":0.2336372837987475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004135549,0.000225406,0.0008269796,0.0001736531,0.00005861526,0.00002803536,0.0002853542,0.00003475301,0.0004193652],"category_scores_gemma":[0.0003099141,0.0001658304,0.000252835,0.0002334393,0.0001093308,0.0001610383,0.0000573232,0.0003268966,0.00002299073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004113159,"about_ca_system_score_gemma":0.00007036843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.714008e-7,"about_ca_topic_score_gemma":1.744188e-7,"domain_scores_codex":[0.9976686,0.0006471939,0.0009202607,0.0002197474,0.0003855049,0.0001587014],"domain_scores_gemma":[0.9976981,0.0001922657,0.001762927,0.000138051,0.0001102579,0.00009838815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002029827,0.00002523863,0.000003546399,0.001360355,0.00001856149,0.00007421661,0.00004129338,0.00001134131,0.00395444,0.00004014327,0.003706474,0.9907441],"study_design_scores_gemma":[0.0001898404,0.0001765817,0.00002692278,0.009088021,0.0001656679,0.0001122178,0.000001712056,0.000002820891,0.002728414,0.000005821129,0.987354,0.0001479977],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002382957,0.9978516,0.00004168562,0.00006353981,0.0004959846,0.0001147371,0.00002669875,0.000007280057,0.001160185],"genre_scores_gemma":[0.001435221,0.9968629,0.000095802,0.00009494297,0.0006752719,0.000001098204,7.289442e-7,0.00005594752,0.0007780935],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9905961,"threshold_uncertainty_score":0.6762369,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039704180","doi":"10.1016/j.ejca.2013.01.035","title":"Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group","year":2013,"lang":"de","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Retrospective cohort study; Stage (stratigraphy); Prospective cohort study; Ovarian cancer; Cohort; Internal medicine; Oncology; Cancer; Multivariate analysis; Cohort study; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.02453138160869398,"gpt":0.2950203833766818,"spread":0.2704890017679878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002660101,0.0004879223,0.001296451,0.0001523759,0.0001876482,0.00004514091,0.00126003,0.00005795477,0.000905608],"category_scores_gemma":[0.0004482788,0.0002377159,0.0005545167,0.0006724662,0.0003828508,0.0001444274,0.0004974189,0.001003465,0.00003594186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002533019,"about_ca_system_score_gemma":0.0005218071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001227247,"about_ca_topic_score_gemma":0.0002910013,"domain_scores_codex":[0.9931753,0.002458762,0.001993768,0.0004368242,0.001460072,0.0004752984],"domain_scores_gemma":[0.9942054,0.0002544896,0.002998658,0.001308847,0.001023182,0.0002094832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003734796,0.008710083,0.9608638,0.00006310015,0.004610127,0.0002370949,0.003122283,0.0003558099,0.0001494814,0.00001785258,0.009539196,0.01195773],"study_design_scores_gemma":[0.00928001,0.008697624,0.9635856,0.0007685225,0.006304737,0.0000160532,0.004586127,0.00001627831,0.0003388393,0.00001309233,0.006194017,0.0001990667],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9512736,0.03338687,0.000009233805,0.006267151,0.004319838,0.003369326,0.00002905704,0.000009982558,0.001334918],"genre_scores_gemma":[0.9941238,0.003286583,0.00006271635,0.0005018284,0.00137707,0.00005728474,9.527577e-7,0.00008584664,0.0005039864],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04285011,"threshold_uncertainty_score":0.9915772,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3007541271","doi":"10.1016/j.ejca.2020.01.007","title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Instituto Superior de Agronomia; Merck Sharp and Dohme; Sandoz; Bristol-Myers Squibb Canada; Genentech; Sun Pharma; Genesis Pharma; Eisai; SkylineDx; Pfizer; Biogen; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Mylan; Galderma; UCB; AbbVie; Health Research; Novartis; Celgene; LEO Pharma; Bayer; Wyeth; Agence Nationale de la Recherche; Roche; Sanofi; Merck; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Guideline; Epidemiology; Medicine; Basal cell; Dermatology; Oncology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0533766450898083,"gpt":0.3284284051082279,"spread":0.2750517600184196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090134,0.0001701194,0.0004616238,0.00004906287,0.00007434258,0.000005204784,0.0002206349,0.00001782966,0.00006860183],"category_scores_gemma":[0.001231599,0.0001078906,0.0001945794,0.0001166881,0.0002023459,0.00004488059,0.0004021873,0.0003862052,0.00001041713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006233712,"about_ca_system_score_gemma":0.0001088723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003486666,"about_ca_topic_score_gemma":0.00000793605,"domain_scores_codex":[0.9975153,0.0009485409,0.0009564435,0.0001913893,0.0002174848,0.0001708848],"domain_scores_gemma":[0.9980289,0.0004050313,0.0009345339,0.0002106483,0.0002556542,0.0001651788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001546258,0.0002390826,0.4915882,0.000499207,0.0002807885,0.001150594,0.006715632,0.0005854922,0.001369119,0.00003924984,0.4391683,0.05681812],"study_design_scores_gemma":[0.002963706,0.003763928,0.9416781,0.0007465651,0.0003881851,0.0001416136,0.0006809816,0.00002100259,0.004384547,0.00006226807,0.04501544,0.0001536461],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9282904,0.0192052,0.0003217097,0.03131709,0.0008944783,0.0003016769,0.00002864193,0.000008712818,0.01963211],"genre_scores_gemma":[0.9928238,0.001418798,0.0005092874,0.003273098,0.001686533,0.000001255299,0.000001721231,0.0000438074,0.0002416405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.45009,"threshold_uncertainty_score":0.439965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010480908","doi":"10.1016/j.ejca.2013.12.005","title":"Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional mismatch repair deficiency consortium","year":2014,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; SickKids Foundation; University of Toronto; Public Health Ontario; Hospital for Sick Children; Mount Sinai Hospital","funders":"","keywords":"Medicine; Lynch syndrome; DNA mismatch repair; Asymptomatic; Microsatellite instability; Genetic testing; Cancer; Asymptomatic carrier; Immunohistochemistry; Germline mutation; Germline; Internal medicine; Oncology; Mutation; Gene; Colorectal cancer; Genetics; Microsatellite; Biology; Allele","retraction":null,"screen_n_in":null,"score":{"opus":0.02935354911449617,"gpt":0.3149319415972027,"spread":0.2855783924827066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002712454,0.0002672002,0.0007219616,0.00009038096,0.0001782235,0.00002355446,0.0003079376,0.0000884653,0.0003614273],"category_scores_gemma":[0.002031437,0.0001842724,0.0004512747,0.000197253,0.00422183,0.00007646704,0.0001248425,0.0005369618,0.00001561526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000110938,"about_ca_system_score_gemma":0.001512708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004935926,"about_ca_topic_score_gemma":0.00002350349,"domain_scores_codex":[0.9955903,0.000594347,0.002092478,0.0004466396,0.0009496001,0.0003266168],"domain_scores_gemma":[0.9963934,0.000661198,0.001305444,0.0005309916,0.0008080303,0.000300901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003381595,0.0001918353,0.9844241,0.00007885673,0.0001676252,0.001906657,0.0001440739,0.000125769,0.0005721456,0.0002563106,0.006253549,0.005540882],"study_design_scores_gemma":[0.002100642,0.0009276022,0.9597978,0.00063949,0.0005747321,0.01387431,0.00009924507,0.0003327037,0.0002645166,0.0001124566,0.02105301,0.0002234827],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820623,0.008893269,0.001466413,0.0005094458,0.002045163,0.0002812723,0.00005076935,0.00003950365,0.004651813],"genre_scores_gemma":[0.9917815,0.0006775834,0.006281643,0.0005454021,0.000510596,0.000003795115,0.000003003347,0.00002308937,0.0001734277],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02462633,"threshold_uncertainty_score":0.9984881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949516084","doi":"10.1016/j.ejca.2019.04.031","title":"Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients","year":2019,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Chugai Pharmaceutical; Ipsen; Glenmark Pharmaceuticals; Helsinn; Genomic Health; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Celgene; Eisai; Sanofi; Pfizer; Amgen","keywords":"Geriatric oncology; Medicine; Prostate cancer; Management of prostate cancer; Oncology; Internal medicine; Cancer; Clinical Oncology; Geriatric care; General surgery; Family medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.04751093748395048,"gpt":0.3749914762008205,"spread":0.32748053871687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004079009,0.00020903,0.0009530722,0.0001926455,0.00001798797,0.000007419364,0.0002981888,0.00004259342,0.0002297415],"category_scores_gemma":[0.00001135851,0.0001221883,0.0005425455,0.0003157445,0.00004324107,0.00004645841,0.0001143327,0.0003642529,0.000006885712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001220107,"about_ca_system_score_gemma":0.0006277066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001972157,"about_ca_topic_score_gemma":0.000006443958,"domain_scores_codex":[0.9979391,0.0002175199,0.001135358,0.0001819342,0.0003823091,0.0001437884],"domain_scores_gemma":[0.9972628,0.00005153147,0.002048662,0.0002261661,0.0003583503,0.00005249289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009839481,0.0005891051,0.002793054,0.002274987,0.001442615,0.00001461997,0.0002422256,0.00003976082,5.068703e-7,0.000009729695,0.07069143,0.9218036],"study_design_scores_gemma":[0.003270238,0.0004054529,0.01246038,0.0180543,0.001308344,0.000004065742,0.00003013183,0.000001592095,0.00001215675,0.000001654437,0.9643639,0.00008780654],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001497827,0.9846477,0.000001364321,0.003204468,0.002515975,0.001536233,0.0003749696,0.000003045185,0.006218452],"genre_scores_gemma":[0.0007020494,0.9970012,0.0001451459,0.000359158,0.0001579529,0.00004697863,0.0000470125,0.00004000154,0.001500456],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9217158,"threshold_uncertainty_score":0.4982693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241605155","doi":"10.1016/j.ejca.2012.06.013","title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012","year":2012,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Cancer Research UK","keywords":"Medicine; Ipilimumab; Melanoma; Guideline; Oncology; Vemurafenib; Internal medicine; Stage (stratigraphy); Systemic therapy; Adjuvant therapy; Skin cancer; Cancer; Surgery; Dermatology; Breast cancer; Immunotherapy; Pathology; Cancer research; Metastatic melanoma","retraction":null,"screen_n_in":null,"score":{"opus":0.02186877716028896,"gpt":0.2939923508756755,"spread":0.2721235737153865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005373071,0.000144293,0.0002000025,0.00005488621,0.00003939696,0.000008828515,0.0001162366,0.00001957381,0.0001007781],"category_scores_gemma":[0.00002277874,0.0001072859,0.0001172305,0.00003363803,0.00007897287,0.000006439956,0.00009010505,0.00004843455,0.000009547345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001598511,"about_ca_system_score_gemma":0.00004549365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002527004,"about_ca_topic_score_gemma":0.000006563845,"domain_scores_codex":[0.9988063,0.0003289067,0.0004684728,0.0001138043,0.0001028365,0.0001796919],"domain_scores_gemma":[0.9991208,0.00001401531,0.0003724738,0.0001804918,0.0001396029,0.0001726013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00112851,0.0007785621,0.09784544,0.00005877102,0.0006394321,0.0003020621,0.0007492624,0.0001953598,0.3584085,0.00003640344,0.115179,0.4246787],"study_design_scores_gemma":[0.002150078,0.001971819,0.04530575,0.00008286115,0.000152709,0.000115075,0.00008334551,0.000009666508,0.1442134,0.000003635474,0.8057063,0.0002054331],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9669774,0.02678214,0.0004290786,0.0007223277,0.0004452781,0.00007512426,0.00004889371,0.000003562952,0.00451622],"genre_scores_gemma":[0.9952442,0.001842096,0.001313735,0.000196635,0.001062868,0.000001672551,0.00001607928,0.00003401763,0.0002886825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6905273,"threshold_uncertainty_score":0.4374991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056804360","doi":"10.1016/j.ejca.2004.07.006","title":"The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications","year":2004,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Ubiquitin; Degradation (telecommunications); Cancer; Protein degradation; Cancer research; Chemistry; Medicine; Cell biology; Biology; Internal medicine; Biochemistry; Computer science; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.04496515888565151,"gpt":0.3253547438544869,"spread":0.2803895849688354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006943,0.0002808109,0.0004689239,0.00009111677,0.0001219878,0.00006442281,0.0006082822,0.00009941485,0.00002894749],"category_scores_gemma":[0.000100392,0.0001797157,0.0003141535,0.0002240159,0.00008318372,0.00000643438,0.00007233227,0.0004805897,0.00001473847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000157508,"about_ca_system_score_gemma":0.001432563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001605664,"about_ca_topic_score_gemma":0.00007922338,"domain_scores_codex":[0.9977145,0.0007467703,0.0008339651,0.0002340906,0.0001930311,0.0002776837],"domain_scores_gemma":[0.9982574,0.00003672982,0.001067058,0.0003250534,0.0002174275,0.00009634132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000210052,0.00002854647,0.000008049057,0.0005681511,0.0001268008,0.000011586,0.00002736082,0.000009793743,0.002119414,0.00008730981,0.0001556402,0.9968364],"study_design_scores_gemma":[0.0003534038,0.0001722076,0.00005505949,0.004754673,0.00007824738,0.00003909065,0.00001071157,2.478527e-7,0.00183367,0.0000372508,0.9924588,0.000206705],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002894508,0.9973888,0.0001159124,0.0004007009,0.0002494919,0.0006067498,0.00009752228,0.000005581478,0.0008457677],"genre_scores_gemma":[0.001619359,0.9965252,0.00005816577,0.00009811238,0.0007504442,0.0001381863,0.00005216905,0.00007918065,0.0006791292],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9966297,"threshold_uncertainty_score":0.7328594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2044736010","doi":"10.1016/j.ejca.2010.10.026","title":"Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials","year":2010,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Hong Kong Cancer Fund","keywords":"Nasopharyngeal carcinoma; Medicine; Regimen; Oncology; Cisplatin; Radiation therapy; Internal medicine; Adjuvant; Fluorouracil; Chemoradiotherapy; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1000790975413753,"gpt":0.404205237086043,"spread":0.3041261395446677,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00211556,0.0002090304,0.001339294,0.0001184553,0.0001034192,0.00001163826,0.0001973703,0.00002722438,0.00005634868],"category_scores_gemma":[0.001487798,0.0001161798,0.0003592315,0.0001698948,0.0001736094,0.00005819861,0.00004819158,0.0002783193,3.822483e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003487441,"about_ca_system_score_gemma":0.0002242582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001869463,"about_ca_topic_score_gemma":0.00002256768,"domain_scores_codex":[0.9978496,0.0002211587,0.001123654,0.0001675106,0.0003606641,0.0002773662],"domain_scores_gemma":[0.9966706,0.0009635086,0.001134355,0.0001840525,0.0008634502,0.0001840561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01392805,0.0005191697,0.1496686,0.0004418155,0.002496818,0.00004501388,0.007278853,0.0001040406,0.5456845,0.0001711292,0.009122844,0.2705392],"study_design_scores_gemma":[0.02468224,0.003228304,0.8549617,0.0006296806,0.0007256253,0.00001654184,0.0004547842,0.0000320382,0.09098241,0.000009587519,0.02409208,0.0001850383],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860036,0.008695257,0.000366227,0.003225759,0.0008158428,0.0006227495,0.00009765888,0.000006304253,0.000166591],"genre_scores_gemma":[0.9980754,0.0006113639,0.0002289721,0.0003524386,0.0006148799,0.000005500604,0.000003960942,0.0000321873,0.00007532051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7052931,"threshold_uncertainty_score":0.4737675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054735694","doi":"10.1016/j.ejca.2011.06.006","title":"Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: A perspective from Central America","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"Centers for Disease Control and Prevention","keywords":"Anthropometry; Medicine; Malnutrition; Psychological intervention; Pediatrics; Percentile; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03006569134868687,"gpt":0.3356621548833044,"spread":0.3055964635346176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002980456,0.0002195013,0.0006660054,0.0001498689,0.00004772465,0.00001624333,0.0001509353,0.00003692075,0.000871781],"category_scores_gemma":[0.0001530988,0.000171584,0.0001676917,0.0002132602,0.0001720338,0.0001191966,0.00008048335,0.0005407651,0.0000157053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004790899,"about_ca_system_score_gemma":0.0002694927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005651427,"about_ca_topic_score_gemma":0.0008646327,"domain_scores_codex":[0.9974867,0.0004103182,0.000836345,0.0003551814,0.0005451078,0.0003663495],"domain_scores_gemma":[0.9983602,0.00006846453,0.0004830399,0.0001898578,0.0002720346,0.0006263935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00243012,0.0004836542,0.9773894,0.00001153325,0.0006199263,0.0001601408,0.01063241,0.000004077473,0.00000631572,0.000002445892,0.003409616,0.004850388],"study_design_scores_gemma":[0.007395798,0.0009443834,0.9872614,0.001607761,0.0002340325,0.00004074021,0.0006573293,0.000001209782,0.0000585184,0.00002169709,0.00157644,0.0002006478],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869559,0.005291942,0.00001341134,0.006488183,0.0003217262,0.0003098569,0.0002781589,0.0000144754,0.000326294],"genre_scores_gemma":[0.9860815,0.006397291,0.0008622339,0.006103464,0.0004243863,0.000007263015,0.00000451416,0.00005101183,0.00006828286],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009975076,"threshold_uncertainty_score":0.9545391,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949515538","doi":"10.1016/j.ejca.2019.05.008","title":"Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Foundation Medicine; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Medicine; Oncology; Internal medicine; Lung cancer; Chemotherapy; Open label; Cancer; Immunotherapy; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.02583722178502796,"gpt":0.3212381747489892,"spread":0.2954009529639613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007201812,0.000434122,0.001013154,0.000121532,0.0001285895,0.0001001373,0.0004069027,0.00005223063,0.0008977606],"category_scores_gemma":[0.00006529102,0.0002537663,0.0002162736,0.0002954858,0.0000845087,0.0002331498,0.00004723295,0.0003527733,0.00001008469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001084008,"about_ca_system_score_gemma":0.001481649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004202113,"about_ca_topic_score_gemma":0.0008734255,"domain_scores_codex":[0.9967621,0.0002604862,0.001490563,0.0004507583,0.0006622167,0.0003738664],"domain_scores_gemma":[0.9969842,0.0003575607,0.00168596,0.0004501919,0.000351438,0.0001706387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9424196,0.00091094,0.0004922486,0.00001894729,0.002007097,0.0006720239,0.003631574,0.003062141,0.00614513,4.482654e-7,0.0006068337,0.04003297],"study_design_scores_gemma":[0.9665295,0.009960557,0.004053315,0.0007655171,0.0006345913,0.00003729578,0.0006001304,0.0004394968,0.00538084,0.000001729085,0.01126731,0.0003296897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851326,0.003748845,0.00002158456,0.004651016,0.001797335,0.003218716,0.0001337003,0.00001718787,0.001278993],"genre_scores_gemma":[0.9915171,0.003297584,0.0003180561,0.0008506452,0.0007401135,0.0001060825,0.00006432585,0.00009914552,0.003006929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03970328,"threshold_uncertainty_score":0.9999915,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979321534","doi":"10.1016/j.ejca.2011.09.005","title":"Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":214,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre hospitalier universitaire de Québec; Saskatchewan Cancer Agency; CancerCare Manitoba; Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; British Columbia Children's Hospital; Children's Hospital of Eastern Ontario; Children's Hospital of Western Ontario; McGill University; Alberta Children's Hospital; Stollery Children's Hospital; Hospital for Sick Children; McMaster University","funders":"","keywords":"Central nervous system; Medicine; Pathology; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01645005950500219,"gpt":0.2363133910167354,"spread":0.2198633315117332,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004807443,0.0001538267,0.000156405,0.00004894947,0.000175813,0.00005344464,0.0004521036,0.00004011583,0.00007572179],"category_scores_gemma":[0.00007242884,0.000105896,0.0001464994,0.00009375758,0.0001124492,0.000007974934,0.00004602096,0.0002250518,0.000009784982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001127068,"about_ca_system_score_gemma":0.0005852743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001802444,"about_ca_topic_score_gemma":0.004982022,"domain_scores_codex":[0.9985342,0.0002954561,0.0004094293,0.0001788726,0.0002168809,0.0003651582],"domain_scores_gemma":[0.9989724,0.000009467034,0.0002722823,0.0002216599,0.000207094,0.0003170746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003058335,0.0003524647,0.134533,0.0003191228,0.0009990819,0.003977447,0.02699897,0.006883279,0.3571953,0.0009113245,0.3007179,0.1640538],"study_design_scores_gemma":[0.004234597,0.0017527,0.4528745,0.0006767664,0.0003208103,0.003529003,0.006032348,0.001059015,0.1286775,0.00003204981,0.399184,0.001626789],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854798,0.00667645,0.0005992777,0.000725825,0.001026161,0.00009245817,0.0000163829,0.000009157219,0.005374535],"genre_scores_gemma":[0.9968919,0.0001932334,0.0002200118,0.000815992,0.00153746,0.000003232027,0.000002185614,0.00003275902,0.000303201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3183416,"threshold_uncertainty_score":0.4318314,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089817687","doi":"10.1016/j.ejca.2009.12.007","title":"The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation","year":2010,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Concordance; Population; Staging system; AJCC staging system; Stage (stratigraphy); Proportional hazards model; Cancer staging; Oncology; Internal medicine; Cohort; Survival analysis; Relative survival; European union; Cancer; Cancer registry","retraction":null,"screen_n_in":null,"score":{"opus":0.01558272601117276,"gpt":0.2783889250852731,"spread":0.2628061990741004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003459404,0.0001941409,0.0003211582,0.00007703809,0.0004536899,0.0001222366,0.000702497,0.000007211499,0.000008944361],"category_scores_gemma":[0.0001920478,0.0000914307,0.0001516169,0.0003922848,0.0001283846,0.00007779585,0.00011649,0.0005083721,0.000005411921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001340976,"about_ca_system_score_gemma":0.0002301847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001715776,"about_ca_topic_score_gemma":0.0005482304,"domain_scores_codex":[0.9972654,0.000656974,0.0008535813,0.0001989448,0.0007192884,0.0003058072],"domain_scores_gemma":[0.9974996,0.00033105,0.0008739412,0.0003184409,0.0008126817,0.0001642693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003804303,0.0003677203,0.4349535,0.0004094869,0.002442193,0.001986861,0.02025121,0.0526018,0.001313085,0.0003586357,0.01543691,0.4660743],"study_design_scores_gemma":[0.003441547,0.001806667,0.9175395,0.002306985,0.0009115924,0.0007080085,0.02311845,0.004411791,0.0004674135,7.652759e-7,0.04495569,0.0003316043],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889339,0.0003115213,0.002021502,0.005178231,0.001707683,0.0009451755,0.00003721387,0.00002483858,0.0008399246],"genre_scores_gemma":[0.9955538,0.00003460483,0.0001599616,0.000407234,0.003571361,0.00002762393,0.000003484012,0.00005743168,0.0001844981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.482586,"threshold_uncertainty_score":0.3728436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165857410","doi":"10.1016/j.ejca.2010.04.004","title":"Nasopharyngeal carcinoma: The next challenges","year":2010,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nasopharyngeal carcinoma; Carcinoma; Medicine; General surgery; Internal medicine; Radiation therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1486540910368331,"gpt":0.3740922312338428,"spread":0.2254381401970098,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001046801,0.0003507184,0.001859501,0.0001282732,0.0001092674,0.00003069751,0.0004167087,0.00007278306,0.0002044768],"category_scores_gemma":[0.0001045421,0.0001705095,0.0007966643,0.000133123,0.0001422266,0.00006836424,0.00009444744,0.001780884,0.00007694093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001109296,"about_ca_system_score_gemma":0.0007378032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003984013,"about_ca_topic_score_gemma":0.0000125438,"domain_scores_codex":[0.9978402,0.0004124116,0.0008263696,0.0001978494,0.0004473348,0.0002757812],"domain_scores_gemma":[0.9981697,0.0001374341,0.0008235513,0.0003699208,0.0002957597,0.0002036911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002908126,0.0000259778,0.000004883014,0.003232143,0.0003338039,0.0007348286,0.0003523495,3.507257e-8,0.000001640346,0.00001895044,0.01178503,0.9834813],"study_design_scores_gemma":[0.0005767955,0.0003770136,0.0003821308,0.01225287,0.001808153,0.0009929206,0.00005851244,1.152246e-7,0.000001289195,0.000001609955,0.9833952,0.0001534521],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004189223,0.9626653,7.56532e-7,0.002813919,0.002158339,0.0002347023,0.000009096165,0.00001088604,0.03206507],"genre_scores_gemma":[0.0003277871,0.9908415,0.00004354968,0.0003377705,0.006914985,0.000007862703,0.000001253802,0.00009982904,0.001425484],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9833278,"threshold_uncertainty_score":0.7737153,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155777530","doi":"10.1016/j.ejca.2011.04.030","title":"Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Dacarbazine; Temozolomide; Medicine; Nausea; Phases of clinical research; Adverse effect; Clinical endpoint; Internal medicine; Oncology; Chemotherapy; Surgery; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.05815835894789728,"gpt":0.3220258166822701,"spread":0.2638674577343729,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001745394,0.0002193649,0.0006720191,0.0004271966,0.00003986126,0.00001333972,0.0002026408,0.00003074741,0.0006343825],"category_scores_gemma":[0.0002707507,0.0001740752,0.0001883819,0.0003456195,0.00007435595,0.00009283124,0.00006602611,0.0004309912,0.00001353402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000138538,"about_ca_system_score_gemma":0.0001466202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001023399,"about_ca_topic_score_gemma":0.0001212866,"domain_scores_codex":[0.9971997,0.0004624616,0.001364669,0.0002453146,0.0004726441,0.0002552154],"domain_scores_gemma":[0.9982197,0.00006946847,0.0008841,0.0003271219,0.000281597,0.0002180504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8775952,0.005490726,0.00190147,0.00009469198,0.001651502,0.02057713,0.005965929,0.0001104904,0.01812651,0.00002600774,0.002248886,0.06621148],"study_design_scores_gemma":[0.8611383,0.01642077,0.09538477,0.0004441297,0.001048368,0.0003150415,0.002893524,0.0003221876,0.006690969,0.00000492796,0.01497483,0.0003621671],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9732952,0.0005367622,0.00007884991,0.0001231278,0.0007402488,0.0007757115,0.00001367066,0.00002291707,0.02441353],"genre_scores_gemma":[0.9959835,0.0001731514,0.0003367546,0.00006212264,0.0002182512,0.000006222331,0.000003129207,0.00003983797,0.003177002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0934833,"threshold_uncertainty_score":0.7098582,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2157334646","doi":"10.1016/j.ejca.2012.01.038","title":"Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium","year":2012,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Memorial Sloan-Kettering Cancer Center; National Cancer Institute; Massachusetts General Hospital","keywords":"Lung cancer; Medicine; Family history; Odds ratio; Internal medicine; Confounding; Family aggregation; Cancer; Confidence interval; Relative risk; Oncology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01066530434403238,"gpt":0.2941586248469896,"spread":0.2834933205029572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537305,0.0001500806,0.0003973515,0.0001741905,0.00003721652,0.00000896254,0.0002880458,0.00001747996,0.0007829875],"category_scores_gemma":[0.00009347669,0.00007660949,0.000251308,0.0003742912,0.0001542694,0.0001392251,0.00004748381,0.0002601464,3.685729e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001003402,"about_ca_system_score_gemma":0.001474583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006335754,"about_ca_topic_score_gemma":0.001106296,"domain_scores_codex":[0.998125,0.0003596906,0.0005736044,0.0001288795,0.0006392313,0.0001735564],"domain_scores_gemma":[0.9979107,0.0001306834,0.001158505,0.0002641706,0.0003808545,0.00015511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004481188,0.0001617657,0.9756214,0.00002430133,0.009875779,0.00001465516,0.003426263,0.001566767,0.0004666009,0.000008497358,0.006146896,0.00223895],"study_design_scores_gemma":[0.002952166,0.00003191682,0.9695449,0.0006740473,0.01738459,0.000001891671,0.0002152438,0.0003375157,0.00009032451,0.00000160674,0.008684649,0.00008116139],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.904706,0.09084564,0.00006646381,0.00151537,0.000646321,0.0002572675,0.0007557159,0.000003888028,0.001203351],"genre_scores_gemma":[0.995818,0.002357389,0.00008353055,0.0006712532,0.0004181663,0.00002602969,0.00000910549,0.00002594929,0.0005906192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09111197,"threshold_uncertainty_score":0.9577807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997274895","doi":"10.1016/j.ejca.2003.06.001","title":"Melanoma in children and adolescents","year":2003,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Melanoma; Medicine; CDKN2A; Natural history; Disease; Epidemiology; Cancer; Pediatrics; Xeroderma pigmentosum; Dermatology; Oncology; Internal medicine; Genetics; Cancer research; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02033153558157238,"gpt":0.2996194374061013,"spread":0.2792879018245289,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003962193,0.0001815562,0.0008117462,0.0003030959,0.00001515517,0.00001918641,0.00008540458,0.00003201559,0.0001207425],"category_scores_gemma":[0.00002110698,0.0001312918,0.0001957407,0.0001374318,0.00002300518,0.00002308526,0.00003110772,0.0004410848,0.00002585239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00012351,"about_ca_system_score_gemma":0.00009639478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003428892,"about_ca_topic_score_gemma":0.000002686844,"domain_scores_codex":[0.9987018,0.0002660115,0.0005738226,0.0001356503,0.0001934827,0.0001292259],"domain_scores_gemma":[0.9992526,0.000006400361,0.0004440581,0.0001218067,0.00004539572,0.0001297543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002230456,0.00003369422,0.0008777715,0.001348642,0.000177847,0.0007887234,0.00001489998,2.199975e-7,2.180586e-7,0.000001706484,0.001457648,0.9952763],"study_design_scores_gemma":[0.0008369571,0.0001724614,0.005784712,0.02045784,0.0006818077,0.005140475,0.000004086498,1.161729e-7,2.632574e-7,5.210389e-7,0.9668123,0.0001084451],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004120134,0.9951057,0.000007937474,0.00003079765,0.0003747716,0.000276889,0.000003115695,0.000005010337,0.003783744],"genre_scores_gemma":[0.0006330168,0.9970095,0.00004814445,0.0001577255,0.0003800374,0.000001153992,0.000001111275,0.00004688224,0.001722482],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9951679,"threshold_uncertainty_score":0.5353926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973942156","doi":"10.1016/j.ejca.2008.10.027","title":"Individual patient data analysis to assess modifications to the RECIST criteria","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":201,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Medical physics","retraction":null,"screen_n_in":null,"score":{"opus":0.1216553627625872,"gpt":0.3557272994793777,"spread":0.2340719367167905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003006827,0.00009797892,0.000137894,0.00007519517,0.0001504897,0.00002880638,0.00062772,0.00001000572,0.00003636254],"category_scores_gemma":[0.00008453991,0.0000657509,0.00007703512,0.0002909188,0.00003680336,0.000006425709,0.0003253233,0.00006303751,0.00001434228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002481908,"about_ca_system_score_gemma":0.00007906432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003270118,"about_ca_topic_score_gemma":0.0001353095,"domain_scores_codex":[0.9990045,0.0001782592,0.0002648435,0.0002005371,0.0002259835,0.0001258967],"domain_scores_gemma":[0.9989045,0.00001180379,0.0001538922,0.0005828111,0.0002404427,0.0001065271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005725996,0.0003177107,0.0304403,0.000005769251,0.008294967,0.000140682,0.00554414,0.009515224,0.01568255,0.00001496485,0.7585123,0.1709588],"study_design_scores_gemma":[0.0003275825,0.0002274383,0.3964309,0.00001473327,0.0006453259,0.00006361471,0.0002323291,0.000008308667,0.003847518,0.00000108111,0.5980529,0.0001483251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9699789,0.004331404,0.01165692,0.01005133,0.0006026877,0.0001798405,0.0008785541,0.000006075545,0.002314318],"genre_scores_gemma":[0.9953755,0.0003992433,0.002263957,0.001116997,0.0005712127,0.000006246327,0.00004867191,0.00001566839,0.0002024971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3659905,"threshold_uncertainty_score":0.2681244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995662976","doi":"10.1016/s0959-8049(03)00630-0","title":"An open randomised trial of second-line endocrine therapy in advanced breast cancer","year":2003,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":192,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Oncology; Cancer; Breast cancer; Endocrine system; Internal medicine; Gynecology; Hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.01086070817499213,"gpt":0.303620751370226,"spread":0.2927600431952339,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000739167,0.0001332275,0.0002943143,0.00005538852,0.00002346624,0.00001836679,0.0003419988,0.00003259705,0.0002547486],"category_scores_gemma":[0.00003387563,0.00009853771,0.0001038715,0.00009383247,0.00004149266,0.00001619123,0.00002806194,0.0001783419,9.28868e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001801658,"about_ca_system_score_gemma":0.0002051445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001300001,"about_ca_topic_score_gemma":0.00002419992,"domain_scores_codex":[0.9984951,0.0005920885,0.0004691607,0.0001529672,0.000124583,0.0001660802],"domain_scores_gemma":[0.9991568,0.00001194634,0.0003885039,0.0001845869,0.0001562979,0.0001019096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1135311,0.0002569345,0.0005824881,0.000007361874,0.0001688373,0.00005878567,0.00006407257,0.001062524,0.8369538,0.000008380974,0.0003729537,0.0469328],"study_design_scores_gemma":[0.3725639,0.004807879,0.003632359,0.0001123411,0.0000385946,0.0001171621,0.0000452211,0.000008212193,0.5885508,0.000012319,0.02988022,0.0002309613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880921,0.008509598,0.00002592585,0.0001100502,0.0004127584,0.0003527429,0.00001729574,0.000001631015,0.002477939],"genre_scores_gemma":[0.9920033,0.006938235,0.0001582448,0.0001482198,0.0003219968,0.000009039447,0.000003831257,0.00003279063,0.0003842961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2590328,"threshold_uncertainty_score":0.4018251,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092281468","doi":"10.1016/j.ejca.2014.03.009","title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","year":2014,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostatectomy; Cohort; Hazard ratio; Urology; Stage (stratigraphy); Proportional hazards model; Carcinoma; Prostate cancer; Pathological; Oncology; Internal medicine; Confidence interval; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01222377423198053,"gpt":0.2717845387000694,"spread":0.2595607644680889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005398132,0.0002035335,0.0005223813,0.0001969525,0.00001967737,0.00001873579,0.00007247417,0.00002376668,0.00005925282],"category_scores_gemma":[0.00007436533,0.0001337755,0.0001654283,0.0001388544,0.00008986652,0.0001051816,0.00003941198,0.0002945505,0.000001433418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001706472,"about_ca_system_score_gemma":0.0003300698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001143707,"about_ca_topic_score_gemma":0.00002550083,"domain_scores_codex":[0.9985706,0.00017063,0.0005557153,0.0001844778,0.0002588006,0.0002598345],"domain_scores_gemma":[0.9990333,0.00005013774,0.000332529,0.0001584352,0.0001977908,0.0002278089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001480554,0.0001867674,0.9804369,0.0001652231,0.0001850399,0.001085938,0.001199006,0.000009476309,0.0004322217,0.000004644028,0.0004130753,0.01440111],"study_design_scores_gemma":[0.005504753,0.00310363,0.9871262,0.0006624794,0.0001427026,0.0003559101,0.00004501233,0.00003235702,0.0009684924,0.0000194306,0.001918756,0.0001203149],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850573,0.01262108,0.0000447166,0.0005082584,0.0001014309,0.000499962,0.00006264361,0.000006038838,0.001098559],"genre_scores_gemma":[0.9991316,0.0002708322,0.000123129,0.0001429146,0.0002362438,0.00001929598,0.000006098177,0.00004051379,0.00002940646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0142808,"threshold_uncertainty_score":0.5455207,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031188948","doi":"10.1016/j.ejca.2011.09.028","title":"Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991","year":2011,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Bundesamt für Zivilluftfahrt","keywords":"Medicine; Internal medicine; Gastroenterology; Stage (stratigraphy); Hazard ratio; Population; Melanoma; Adjuvant; Cancer; Oncology; Confidence interval; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.08544655606687808,"gpt":0.3678701103826715,"spread":0.2824235543157934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002544936,0.0002474263,0.001913389,0.0003191325,0.00002868115,0.00001474567,0.0001421606,0.00005723536,0.00006922221],"category_scores_gemma":[0.0005324548,0.0001445592,0.0003030997,0.0001649558,0.0001189763,0.00005707466,0.00009748239,0.000451125,7.543942e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001091391,"about_ca_system_score_gemma":0.0001656476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003107289,"about_ca_topic_score_gemma":0.00005736152,"domain_scores_codex":[0.9962066,0.001122769,0.002053179,0.0002147377,0.0002792028,0.0001234552],"domain_scores_gemma":[0.9956216,0.0001661233,0.003654607,0.0002544766,0.0001986081,0.0001046252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005570584,0.0002681238,0.00002427835,0.003153139,0.0006515564,0.0002204927,0.001065498,0.00000629984,0.00006153339,0.00001416307,0.0007899197,0.9881744],"study_design_scores_gemma":[0.01611339,0.003121275,0.001594769,0.03014577,0.002844373,0.0003664929,0.0003025211,0.00001180625,0.0001221536,0.000002142696,0.9451991,0.0001762147],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01420179,0.9808143,0.00006037869,0.00008053234,0.0006789103,0.001211738,0.0001554602,0.000005981755,0.002790906],"genre_scores_gemma":[0.1068075,0.8915735,0.00002025408,0.00002521347,0.0003039049,0.00000448566,0.000005216854,0.00003636166,0.001223559],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9879982,"threshold_uncertainty_score":0.5894952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2737912388","doi":"10.1016/j.ejca.2017.06.017","title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Prospective cohort study; Univariate analysis; Sarcoma; Fibromatosis; Surgery; Proportional hazards model; Stage (stratigraphy); Log-rank test; Internal medicine; Oncology; Multivariate analysis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01999929147335474,"gpt":0.2820810608167539,"spread":0.2620817693433992,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000765086,0.000200049,0.0005080131,0.00007217086,0.0002444451,0.00006879874,0.0003679373,0.00003113704,0.00009482064],"category_scores_gemma":[0.0004348236,0.000128092,0.0001560199,0.0001430259,0.0002583886,0.0001983811,0.0001745441,0.0005275324,0.00002126364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002912017,"about_ca_system_score_gemma":0.0001226816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002090065,"about_ca_topic_score_gemma":0.00003712956,"domain_scores_codex":[0.9980085,0.0002625472,0.0005455017,0.0002497597,0.000695642,0.000238047],"domain_scores_gemma":[0.9982131,0.0002977628,0.0005390175,0.0003914742,0.0004270154,0.0001316679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00206178,0.0002490746,0.9865096,0.00001758868,0.0004031133,0.001824848,0.0007428629,0.000006214707,0.0000210591,0.00001212253,0.003223405,0.004928289],"study_design_scores_gemma":[0.01112084,0.0006367862,0.9772635,0.000290837,0.0002102382,0.000122349,0.00009107335,0.00001629517,0.00003292149,0.00001091227,0.01006975,0.0001344726],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9629671,0.002998455,0.00001182591,0.0006381343,0.000752938,0.0003691908,0.00001415174,0.00001351937,0.03223472],"genre_scores_gemma":[0.997502,0.000469374,0.0006300415,0.00007790337,0.001066005,0.00001014489,0.00001209638,0.00003960748,0.0001928379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03453492,"threshold_uncertainty_score":0.5223441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975664877","doi":"10.1016/j.ejca.2019.07.021","title":"The transformation of radiation oncology using real-time magnetic resonance guidance: A review","year":2019,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":182,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"Division of Mathematical Sciences; National Institute of Dental and Craniofacial Research; Medical Research Council; Siemens Healthineers; National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research; National Institutes of Health; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Elekta; Roche; Merck; AstraZeneca; Varian Medical Systems; Cancer Research UK; National Science Foundation","keywords":"Radiation oncology; Transformation (genetics); Medical physics; Magnetic resonance imaging; Medicine; Oncology; Radiation therapy; Internal medicine; Radiology; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03098007322241044,"gpt":0.3769961308231414,"spread":0.346016057600731,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001311357,0.0002240967,0.001152335,0.0000735877,0.00005308906,0.00001593542,0.0004202864,0.00003109143,0.0002187326],"category_scores_gemma":[0.00001251122,0.0001428329,0.0004619033,0.000208947,0.00006421036,0.0001551569,0.00001570579,0.0003486516,0.000006019888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002224843,"about_ca_system_score_gemma":0.0005091192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007226276,"about_ca_topic_score_gemma":1.704523e-7,"domain_scores_codex":[0.9972269,0.0009024821,0.001351883,0.0001177047,0.0002361301,0.0001648953],"domain_scores_gemma":[0.9967213,0.0001353445,0.002627779,0.0002628407,0.0002110869,0.00004170227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001039145,0.00001073216,0.00000265178,0.002539688,0.00006530334,0.000001908255,0.00005420212,0.000009464587,0.00001882329,0.0001186641,0.001769745,0.9953984],"study_design_scores_gemma":[0.0002040736,0.000169318,0.000005321361,0.03549172,0.0004832399,0.00001429434,0.000003015509,0.00001790232,0.00001141957,0.00001519544,0.9634572,0.0001273337],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001361001,0.9880925,0.004368283,0.00006460715,0.0002258714,0.0005271744,0.00003446776,0.000006778653,0.006678917],"genre_scores_gemma":[0.000001958217,0.9965462,0.002410652,0.00003137941,0.0005640718,0.000008657204,0.000004881559,0.00005882485,0.000373388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9952711,"threshold_uncertainty_score":0.5824556,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}